Tiziana Life Sciences Ltd (TLSA) Financials
TLSA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 22.0 million | 5.2 million |
| 2023-03-31 | 32.8 million | 8.6 million |
| 2022-12-31 | 32.0 million | 8.4 million |
| 2022-09-30 | ? | ? |
TLSA Free Cash Flow and Stock based compensation
No data available :(
TLSA Net Income
No data available :(
TLSA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 8.3 million | - | 445646 |
| 2023-03-31 | 22.5 million | - | - |
| 2022-12-31 | 21.9 million | - | 441701 |
| 2022-09-30 | - | - | - |
TLSA Shares Outstanding
TLSA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | - | - | - | - |
| 2023-03-31 | - | 6.8 million | - | - |
| 2022-12-31 | - | - | - | - |
| 2022-09-30 | - | - | - | - |
TLSA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | - | - |
| 2023-03-31 | - | 56994 |
| 2022-12-31 | - | - |
| 2022-09-30 | - | - |
TLSA
Price: $0.71
52 week price:
Earnings Per Share: -0.18 USD
P/E Ratio: -3.58
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 67400
Market Capitalization: 50.1 million